Schnitzler's syndrome: diagnosis, treatment, and follow‐up

Citations Over TimeTop 10% of 2013 papers

Abstract

Schnitzler's syndrome is characterized by recurrent urticarial rash and monoclonal gammopathy, associated with clinical and biological signs of inflammation and a long-term risk of AA amyloidosis and overt lymphoproliferation. An extensive literature review was performed, and the following questions were addressed during an expert meeting: In whom should Schnitzler's syndrome be suspected? How should the diagnosis of Schnitzler's syndrome be established? How should a patient with Schnitzler's syndrome be treated? How should a patient with Schnitzler's syndrome be followed up?. A diagnosis of Schnitzler's syndrome is considered definite in any patient with two obligate criteria: a recurrent urticarial rash and a monoclonal IgM gammopathy, and two of the following minor criteria: recurrent fever, objective signs of abnormal bone remodeling, elevated CRP level or leukocytosis, and a neutrophilic infiltrate on skin biopsy. It is considered probable, if only 1 minor criterion is present. In patients with monoclonal IgG gammopathies, diagnosis is definite if three minor criteria are present and possible if two are present. First-line treatment in patients with significant alteration of quality of life or persistent elevation of markers of inflammation should be anakinra. Follow-up should include clinical evaluation, CBC and CRP every 3 months and MGUS as usually recommended.

Related Papers

• → On the prevalence and genetic predisposition of monoclonal gammopathy of undetermined significance (MGUS)(2012)14 cited
• → Chronic urticaria with monoclonal IgG gammopathy: a clinical variant of Schnitzler syndrome?(2012)6 cited
• → Monoclonal gammopathy in a dog with plasmacytic gastroenterocolitis(1992)18 cited
• → Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance(2014)1 cited
• → M152 SCHNITZLER’S SYNDROME: A RARE MIMICKER OF CHRONIC URTICARIA(2020)